News

Filter

Current filters:

Exenatide Injection

1 to 9 of 112 results

Bristol-Myers sells diabetes alliance assets to AstraZeneca for $4.1 billion

Bristol-Myers sells diabetes alliance assets to AstraZeneca for $4.1 billion

19-12-2013

Confirming recent runors, Anglo-Swedish drug major AstraZeneca revealed this morning that it will acquire…

AstraZenecaBristol-Myers SquibbDiabetesExenatide InjectionMergers & AcquisitionsOnglyzaPharmaceutical

Amylin diabetes drug exenatide deal with Eli Lilly terminated, with $1.45 billion settlement to Lilly

09-11-2011

Shares of US biotech firm Amylin Pharmaceuticals fell 8.4% to $10.01 in pre-market trading yesterday,…

AmylinBiotechnologyBydureonByettaDiabetesEli LillyExenatide InjectionLicensingPharmaceutical

Judge vacates Amylin injunction against Eli Lilly; latter updates Humalog label

09-06-2011

It was a good news day for US drug major Eli Lilly (NYSE: LLY) yesterday, as the firm received approval…

AmylinBoehringer IngelheimDiabetesEli LillyExenatide InjectionHumalogLegallinagliptinNorth AmericaPharmaceuticalRegulation

Amylin wins first round in squabble with Lilly over diabetes link with Boehringer

27-05-2011

In an initial win for US biotech firm Amylin Pharmaceuticals (Nasdaq: AMLN), the US District Court for…

AmylinBoehringer IngelheimDiabetesEli LillyExenatide InjectionLegallinagliptinNorth AmericaPharmaceuticalTradjenta

1 to 9 of 112 results

Back to top